Tag: Pharmaceutical industry and healthcare
Industry payments were linked to more brand-name MS prescribing
Pharmaceutical payments to clinicians correlated with reduced generic prescribing for MS medications, increasing costs for patients and the healthcare system overall.
Most favored nation drug pricing may lower industry research revenue
Analysis of most favored nation drug pricing as policy mechanism to reduce international price disparities and effects on pharmaceutical research investment and innovation.
Turkish drug recalls were driven by contamination, sterility, and safety issues
—
in MedicineSystematic analysis of 133 drug recalls by Turkish regulatory agency 2018-2024, identifying 14 recall reasons with Class A and B classifications predominating.
Drug shortages create risks in obstetric care
Clinical analysis of drug shortages in obstetric care addressing causation, prediction, and systematic response mechanisms for healthcare institutions.
